Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Buy
48,924
+31,420
+180% +$1.17M 0.02% 255
2026
Q1
$699K Buy
+17,504
New +$828K 0.01% 320
2025
Q4
Sell
-13,164
Closed -$586K 450
2025
Q3
$586K Sell
13,164
-5,000
-28% -$239K 0.01% 255
2025
Q2
$867K Buy
18,164
+5,000
+38% +$217K 0.02% 223
2025
Q1
$526K Sell
13,164
-1
-0% -$42 0.01% 251
2024
Q4
$605K Hold
13,165
0.02% 255
2024
Q3
$616K Hold
13,165
0.02% 238
2024
Q2
$555K Hold
13,165
0.02% 267
2024
Q1
$581K Buy
+13,165
New +$600K 0.02% 256

Other funds holding QGEN

Allianz's QGEN Position: Q2 2026 in Review

Allianz increased its Qiagen (QGEN) stake by 180% in Q2 2026, buying an estimated $1.17M and bringing the position to 48,924 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #255.

Allianz first reported a position in QGEN in Q1 2024 and has held it in 9 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Allianz held 48,924 shares of Qiagen worth $1.92M as of Q2 2026.
  • Allianz bought 31,420 Qiagen shares in Q2 2026, an estimated $1.17M.
  • Qiagen made up 0.02% of Allianz's portfolio in Q2 2026, its #255 holding.
  • Allianz first reported a position in Qiagen in Q1 2024 and has held it in 9 quarters since.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.